Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Unstoppable Green Flags for AbbVie

TheMotleyFool

0 0

When it comes to AbbVie (NYSE: ABBV), investors have been worrying about one thing: an eventual drop in sales of its blockbuster Humira. The immunosuppressive drug is used for various diseases, including rheumatoid arthritis.

Last year, Humira generated more than $20 billion in sales. But as of next year, competition may start eating away at Humira's market share.

That may look like terrible news, but there's a big silver lining around this dark cloud. And the following two charts offer us the details.

Source Fool.com

Like: 0

ABBV

Share